Cargando…

Alpha-Klotho in Parkinson’s disease: a perspective on experimental evidence and potential clinical implications

Detalles Bibliográficos
Autores principales:	Grillo, Piergiorgio, Basilicata, Michele, Schirinzi, Tommaso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165369/ https://www.ncbi.nlm.nih.gov/pubmed/35662210 http://dx.doi.org/10.4103/1673-5374.335820

Ejemplares similares

The Interrelated Multifactorial Actions of Cortisol and Klotho: Potential Implications in the Pathogenesis of Parkinson’s Disease
por: Luthra, Nijee S., et al.
Publicado: (2022)

Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson’s Disease
por: Schirinzi, Tommaso, et al.
Publicado: (2022)

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
por: Schirinzi, Tommaso, et al.
Publicado: (2019)

Klotho and neurons: mutual crosstalk between autophagy, endoplasmic reticulum, and inflammatory response
por: Mytych, Jennifer
Publicado: (2021)

Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters
por: Schirinzi, Tommaso, et al.
Publicado: (2022)

Effects of head trauma and sport participation in young-onset Parkinson’s disease
por: Schirinzi, Tommaso, et al.
Publicado: (2021)

Cytoskeletal proteins in the cell nucleus: a special nuclear actin perspective
por: Percipalle, Piergiorgio, et al.
Publicado: (2019)

Alpha-synuclein as a biomarker in Parkinson's disease: focus on neural derived extracelluar vesicles
por: Agliardi, Cristina, et al.
Publicado: (2021)

Cancer Cachexia and Dysregulated Phosphate Metabolism: Insights from Mutant p53 and Mutant Klotho Mouse Models
por: Brown, Ronald B.
Publicado: (2022)

Transmission of amyloid-β pathology in humans: a perspective on clinical evidence
por: Catumbela, Celso S. G., et al.
Publicado: (2023)

FDA perspectives on potential microarray-based clinical diagnostics
por: Težak, Živana, et al.
Publicado: (2006)

Alpha-synuclein preformed fibrils: a tool to understand Parkinson’s disease and develop disease modifying therapy
por: Chmielarz, Piotr, et al.
Publicado: (2021)

Perspectives for the association between olfactory disturbances and depression in Parkinson’s disease
por: Ilkiw, Jessica L., et al.
Publicado: (2019)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Stem Cell Transplantation for Parkinson’s Disease: Current Challenges and Perspectives
por: Zeng, Xinlin, et al.
Publicado: (2022)

Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
por: Cubo, Esther, et al.
Publicado: (2022)

Impact of alpha-synuclein pathology on adult neurogenesis: evidence for multilayered mechanisms
por: Bonsberger, Jana, et al.
Publicado: (2021)

Potential role of biofeedback therapy for Parkinson’s disease
por: Kotani, Naoya, et al.
Publicado: (2021)

Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective
por: Knecht, Luisa, et al.
Publicado: (2022)

Pharmacogenomics in Parkinson’s disease: which perspective for developing a personalized medicine?
por: Ciccacci, Cinzia, et al.
Publicado: (2019)

Double hit mouse model of Parkinson's disease
por: Schirinzi, Tommaso, et al.
Publicado: (2016)

Need for alternatives to animals in experimentation: An Indian perspective
por: Swaminathan, Soumya, et al.
Publicado: (2019)

How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging
por: Zenuni, Henri, et al.
Publicado: (2021)

Protective potential of klotho protein on diabetic retinopathy: Evidence from clinical and in vitro studies
por: Ji, Baolan, et al.
Publicado: (2019)

Parasite co-infection: an ecological, molecular and experimental perspective
por: Venter, Frank, et al.
Publicado: (2022)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hasselbalch, Hans C., et al.
Publicado: (2021)

Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction
por: Di Lazzaro, Giulia, et al.
Publicado: (2018)

Evidences of hydroxytyrosol as an anti-inflammatory agent in Parkinson’s disease: insights into the mechanisms of action
por: Hornedo-Ortega, Ruth, et al.
Publicado: (2020)

A biophysical perspective on the unexplored mechanisms driving Parkinson’s disease by amphetamine-like stimulants
por: Ferreira, Carla, et al.
Publicado: (2021)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Cholinergic input from the pedunculopontine nucleus to the cerebellum: implications for deep brain stimulation in Parkinson's disease
por: Scarnati, Eugenio, et al.
Publicado: (2016)

A central role for mitochondrial-derived vesicles in the innate immune response: implications for Parkinson’s disease
por: Ryan, Thomas A., et al.
Publicado: (2021)

Self-experimentation in the COVID Era: Is it morally justifiable? – A perspective
por: Sinha, Ankit, et al.
Publicado: (2022)

Metabotropic glutamate receptor 1 alpha: a unique receptor variant with variable implications for Alzheimer’s disease pathogenesis
por: Yeung, Jason HY, et al.
Publicado: (2023)

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
por: Müller-Nedebock, Amica C., et al.
Publicado: (2023)

Telecardiology and Remote Monitoring of Implanted Electrical Devices: The Potential for Fresh Clinical Care Perspectives
por: Boriani, Giuseppe, et al.
Publicado: (2007)

Grading Quality of Evidence and Strength of Recommendations: A Perspective
por: Ansari, Mohammed T., et al.
Publicado: (2009)

Sigma-1 receptor: a potential new target for Parkinson's disease?
por: Francardo, Veronica
Publicado: (2014)

Alpha shock
por: Murcko, Mark A., et al.
Publicado: (2012)

The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications for Parkinson’s disease
por: Russo, Isabella
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f86fs832lptp1konj1ctgqrh2n